Request Deal Involvement

EcoR1 Capital and Farallon Capital Management led a $110m Series B round in Affinia Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

CASDIN CAPITAL

bidder

CASDIN CAPITAL

FARALLON CAPITAL MANAGEMENT LLC

bidder

FARALLON CAPITAL MANAGEMENT LLC

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

TCG CROSSOVER

bidder

TCG CROSSOVER

F-PRIME CAPITAL

bidder

F-PRIME CAPITAL

LONZA GROUP LTD

bidder

LONZA GROUP LTD

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

AFFINIA THERAPEUTICS

target

AFFINIA THERAPEUTICS

GV (GOOGLE VENTURES)

bidder

GV (GOOGLE VENTURES)

OCTAGON CAPITAL

bidder

OCTAGON CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

MASS GENERAL BRIGHAM VENTURES

bidder

MASS GENERAL BRIGHAM VENTURES

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - EcoR1 Capital and Farallon Capital Management led a $110m Series B round in Affinia Therapeutics.